American Registry Of Ambulatory Or Acutely Decompensated Heart Failure (AMERICCAASS): Characterization Of The First 2500 Patients
Juan E. Gomez-Mesa,Juliana M. Gutiérrez,Alex D. Sotomayor,Manuela Escalante,Mádelyn R. Valle,Luz T. Cabral,Kwame van der Hilst,Felix Nunura Arrese,Eduardo R. Perna,Mario Speranza
DOI: https://doi.org/10.1016/j.cardfail.2023.10.062
IF: 6.592
2024-01-01
Journal of Cardiac Failure
Abstract:BACKGROUND Heart failure (HF) is a significant health problem with a prevalence around 26 million people worldwide. Prevalence is increasing because of ageing of the population and improved cardiovascular treatment. Except for North America, information about HF for the rest of the continent is limited; therefore, regional clinical research is needed with the aim of creating consolidated data about the diagnosis, behavior, and clinical management of HF in the continent. OBJECTIVE Describe demographic, clinical and hemodynamic characteristics of HF patients in the Americas, based on information collected in the AMERICCAASS Registry. METHODS Descriptive, observational, prospective, multicenter registry, including patients older than 18 years with HF divided into two groups: hospitalized and ambulatory. Sociodemographic, comorbidities, physical examination, laboratory, diagnostic, clinical and hemodynamic variables were included. Information was collected in the REDCap platform. Univariate analysis was performed, qualitative variables were expressed as frequency and percentage. The normality of quantitative variables was found using the Shapiro Wilk test and they were expressed as median and interquartile range. RESULTS The first 2500 patients recruited from 67 institutions in 20 countries in the American continent were included, 882 hospitalized and 1618 ambulatory. Overall median age was 66.2 years (RIC 56.1, 75.3), 59.7% were male. For both groups (hospitalized and ambulatory), the most prevalent comorbidity was arterial hypertension, and the most prevalent etiology was ischemic. More than half of patients for both groups had reduced left ventricular ejection fraction (LVEF) (<40), 61.2% and 58.2%, respectively. In ambulatory patients, NYHA II predominate (57.9%). In hospitalized patients, NYHA III predominate (47.7%), as well as warm/wet hemodynamic profile (62.7%) and decompensated HF as clinical profile (72.1%). (Table 1 and 2). CONCLUSIONS AMERICCAASS registry is the first continental project in patients with HF. The results show a high prevalence of patients with reduced LVEF. The clinical and hemodynamic conditions of ambulatory and hospitalized patients show great similarities with international registries; however, we expect that further analysis may show significant differences in population of the American continent.
cardiac & cardiovascular systems